Cargando…

Measuring recovery in participants with a schizophrenia spectrum disorder: validation of the Individual Recovery Outcomes Counter (I.ROC).

BACKGROUND: To improve recovery in mental health, validated instruments are needed. AIMS: This study evaluates psychometric properties of the Individual Recovery Outcomes Counter (I.ROC) in a Dutch population of participants with a schizophrenia spectrum disorder (SSD). METHODS: 326 participants com...

Descripción completa

Detalles Bibliográficos
Autores principales: Sportel, B. Esther, Aardema, Hettie, Boonstra, Nynke, Arends, Johannes, Rudd, Bridey, Metz, Margot J., Castelein, Stynke, Pijnenborg, Gerdina H.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148501/
https://www.ncbi.nlm.nih.gov/pubmed/37118681
http://dx.doi.org/10.1186/s12888-023-04763-3
_version_ 1785034988281921536
author Sportel, B. Esther
Aardema, Hettie
Boonstra, Nynke
Arends, Johannes
Rudd, Bridey
Metz, Margot J.
Castelein, Stynke
Pijnenborg, Gerdina H.M.
author_facet Sportel, B. Esther
Aardema, Hettie
Boonstra, Nynke
Arends, Johannes
Rudd, Bridey
Metz, Margot J.
Castelein, Stynke
Pijnenborg, Gerdina H.M.
author_sort Sportel, B. Esther
collection PubMed
description BACKGROUND: To improve recovery in mental health, validated instruments are needed. AIMS: This study evaluates psychometric properties of the Individual Recovery Outcomes Counter (I.ROC) in a Dutch population of participants with a schizophrenia spectrum disorder (SSD). METHODS: 326 participants completed the I.ROC at baseline (n = 326), six months (n = 155) and twelve months (n = 84) as part of a routine outcome assessment. Reliability, validity, sensitivity to change, and internal factor structure were examined. RESULTS: Participants evaluated the I.ROC as comprehensive. Internal consistency of the I.ROC (α = 0.88) and test-retest reliability (r = .85, p < .001) are good. Negative moderate correlations with the total score of the PANSS (r=-.50, p < .001) and the HoNOS (r=-.52, p < .001) were found, and a small negative correlation with the FR tool (r=-.36, p < .001). Moderate positive correlation with the MANSA (r = .55, p < .001) and the RAS (r = .60, p < .001) were found. The mean total I.ROC scores increased significantly between time points (F(2,166) = 6.351, p < .005), although differences were small. Confirmatory factor analysis showed that fit indices for the one-, two-, and four-factor model are comparable. CONCLUSIONS: The I.ROC is a valid and reliable instrument, with sensitivity to change, to map recovery in participants with SSD.
format Online
Article
Text
id pubmed-10148501
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101485012023-04-30 Measuring recovery in participants with a schizophrenia spectrum disorder: validation of the Individual Recovery Outcomes Counter (I.ROC). Sportel, B. Esther Aardema, Hettie Boonstra, Nynke Arends, Johannes Rudd, Bridey Metz, Margot J. Castelein, Stynke Pijnenborg, Gerdina H.M. BMC Psychiatry Research BACKGROUND: To improve recovery in mental health, validated instruments are needed. AIMS: This study evaluates psychometric properties of the Individual Recovery Outcomes Counter (I.ROC) in a Dutch population of participants with a schizophrenia spectrum disorder (SSD). METHODS: 326 participants completed the I.ROC at baseline (n = 326), six months (n = 155) and twelve months (n = 84) as part of a routine outcome assessment. Reliability, validity, sensitivity to change, and internal factor structure were examined. RESULTS: Participants evaluated the I.ROC as comprehensive. Internal consistency of the I.ROC (α = 0.88) and test-retest reliability (r = .85, p < .001) are good. Negative moderate correlations with the total score of the PANSS (r=-.50, p < .001) and the HoNOS (r=-.52, p < .001) were found, and a small negative correlation with the FR tool (r=-.36, p < .001). Moderate positive correlation with the MANSA (r = .55, p < .001) and the RAS (r = .60, p < .001) were found. The mean total I.ROC scores increased significantly between time points (F(2,166) = 6.351, p < .005), although differences were small. Confirmatory factor analysis showed that fit indices for the one-, two-, and four-factor model are comparable. CONCLUSIONS: The I.ROC is a valid and reliable instrument, with sensitivity to change, to map recovery in participants with SSD. BioMed Central 2023-04-28 /pmc/articles/PMC10148501/ /pubmed/37118681 http://dx.doi.org/10.1186/s12888-023-04763-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sportel, B. Esther
Aardema, Hettie
Boonstra, Nynke
Arends, Johannes
Rudd, Bridey
Metz, Margot J.
Castelein, Stynke
Pijnenborg, Gerdina H.M.
Measuring recovery in participants with a schizophrenia spectrum disorder: validation of the Individual Recovery Outcomes Counter (I.ROC).
title Measuring recovery in participants with a schizophrenia spectrum disorder: validation of the Individual Recovery Outcomes Counter (I.ROC).
title_full Measuring recovery in participants with a schizophrenia spectrum disorder: validation of the Individual Recovery Outcomes Counter (I.ROC).
title_fullStr Measuring recovery in participants with a schizophrenia spectrum disorder: validation of the Individual Recovery Outcomes Counter (I.ROC).
title_full_unstemmed Measuring recovery in participants with a schizophrenia spectrum disorder: validation of the Individual Recovery Outcomes Counter (I.ROC).
title_short Measuring recovery in participants with a schizophrenia spectrum disorder: validation of the Individual Recovery Outcomes Counter (I.ROC).
title_sort measuring recovery in participants with a schizophrenia spectrum disorder: validation of the individual recovery outcomes counter (i.roc).
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148501/
https://www.ncbi.nlm.nih.gov/pubmed/37118681
http://dx.doi.org/10.1186/s12888-023-04763-3
work_keys_str_mv AT sportelbesther measuringrecoveryinparticipantswithaschizophreniaspectrumdisordervalidationoftheindividualrecoveryoutcomescounteriroc
AT aardemahettie measuringrecoveryinparticipantswithaschizophreniaspectrumdisordervalidationoftheindividualrecoveryoutcomescounteriroc
AT boonstranynke measuringrecoveryinparticipantswithaschizophreniaspectrumdisordervalidationoftheindividualrecoveryoutcomescounteriroc
AT arendsjohannes measuringrecoveryinparticipantswithaschizophreniaspectrumdisordervalidationoftheindividualrecoveryoutcomescounteriroc
AT ruddbridey measuringrecoveryinparticipantswithaschizophreniaspectrumdisordervalidationoftheindividualrecoveryoutcomescounteriroc
AT metzmargotj measuringrecoveryinparticipantswithaschizophreniaspectrumdisordervalidationoftheindividualrecoveryoutcomescounteriroc
AT casteleinstynke measuringrecoveryinparticipantswithaschizophreniaspectrumdisordervalidationoftheindividualrecoveryoutcomescounteriroc
AT pijnenborggerdinahm measuringrecoveryinparticipantswithaschizophreniaspectrumdisordervalidationoftheindividualrecoveryoutcomescounteriroc